Literature DB >> 15726663

Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury.

George K Michalopoulos1, Lindsay Barua, William C Bowen.   

Abstract

Rats with chimeric livers were generated by using the protocol of injecting hepatocytes from dipeptidyl peptidase IV (DPPIV)-positive donors into retrorsine-treated DPPIV-negative recipients subjected to partial hepatectomy. Rats with established chimeric livers were subjected to bile duct ligation, with or without pretreatment with the biliary toxin methylene diamiline (DAPM). Ductules bearing the donor hepatocyte marker DPPIV were seen at 30 days after bile duct ligation. The frequency of the ductules derived from the donor hepatocytes was dramatically enhanced (36-fold) by the pretreatment with DAPM. In conclusion, our results show that hepatocytes can function as facultative stem cells and rescue the biliary epithelium during repair from injury when its proliferative capacity is being compromised.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15726663      PMCID: PMC1821079          DOI: 10.1002/hep.20600

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  39 in total

1.  2-acetylaminofluorene dose-dependent differentiation of rat oval cells into hepatocytes: confocal and electron microscopic studies.

Authors:  Sándor Paku; Peter Nagy; László Kopper; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

Review 2.  Canals of Hering: recent insights and current knowledge.

Authors:  Romil Saxena; Neil Theise
Journal:  Semin Liver Dis       Date:  2004-02       Impact factor: 6.115

3.  In vivo differentiation of rat liver oval cells into hepatocytes.

Authors:  R P Evarts; P Nagy; H Nakatsukasa; E Marsden; S S Thorgeirsson
Journal:  Cancer Res       Date:  1989-03-15       Impact factor: 12.701

4.  Phenotypic heterogeneity within clonogenic ductal cell populations isolated from normal adult rat liver.

Authors:  L Yang; R A Faris; D C Hixson
Journal:  Proc Soc Exp Biol Med       Date:  1993-12

5.  A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins.

Authors:  P Van Eyken; R Sciot; V J Desmet
Journal:  Histopathology       Date:  1989-08       Impact factor: 5.087

6.  Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats.

Authors:  B E Petersen; V F Zajac; G K Michalopoulos
Journal:  Hepatology       Date:  1998-04       Impact factor: 17.425

7.  Appearance of ductular hepatocytes in rat liver after bile duct ligation and subsequent zone 3 necrosis by carbon tetrachloride.

Authors:  A E Sirica; T W Williams
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

8.  [The formation of oval-cell ducts during hepatic carcinogenesis in mice. Its relationship to the pre-existing canals of Hering].

Authors:  V M Faktor; S A Radaeva
Journal:  Ontogenez       Date:  1992 Jul-Aug

9.  A precursor-product relationship exists between oval cells and hepatocytes in rat liver.

Authors:  R P Evarts; P Nagy; E Marsden; S S Thorgeirsson
Journal:  Carcinogenesis       Date:  1987-11       Impact factor: 4.944

10.  The canals of hering might represent a target of methotrexate hepatic toxicity.

Authors:  Prodromos Hytiroglou; Hillel Tobias; Romil Saxena; Martha Abramidou; Constantine S Papadimitriou; Neil D Theise
Journal:  Am J Clin Pathol       Date:  2004-03       Impact factor: 2.493

View more
  125 in total

Review 1.  Mammalian cell dedifferentiation as a possible outcome of stress.

Authors:  Ofer Shoshani; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

2.  Phenotypic fidelity (or not?) of epithelial cells in the liver.

Authors:  George K Michalopoulos
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

3.  Probing hepatocyte heterogeneity.

Authors:  Ben Z Stanger
Journal:  Cell Res       Date:  2015-09-25       Impact factor: 25.617

Review 4.  Liver progenitor cells-mediated liver regeneration in liver cirrhosis.

Authors:  Haitao Shang; Zhijun Wang; Yuhu Song
Journal:  Hepatol Int       Date:  2016-01-07       Impact factor: 6.047

5.  Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation.

Authors:  Shirish Paranjpe; William C Bowen; Wendy M Mars; Anne Orr; Meagan M Haynes; Marie C DeFrances; Silvia Liu; George C Tseng; Anastasia Tsagianni; George K Michalopoulos
Journal:  Hepatology       Date:  2016-10-01       Impact factor: 17.425

6.  Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.

Authors:  Vikas Gupta; Ishaan Gupta; Jiwoon Park; Yaron Bram; Robert E Schwartz
Journal:  Gastroenterology       Date:  2020-04-11       Impact factor: 22.682

7.  FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration.

Authors:  Hinako M Takase; Tohru Itoh; Seitaro Ino; Ting Wang; Takehiko Koji; Shizuo Akira; Yasuhiro Takikawa; Atsushi Miyajima
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

8.  Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

Authors:  Jing-Lin Xia; Chunsun Dai; George K Michalopoulos; Youhua Liu
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

9.  Lineage fate of ductular reactions in liver injury and carcinogenesis.

Authors:  Simone Jörs; Petia Jeliazkova; Marc Ringelhan; Julian Thalhammer; Stephanie Dürl; Jorge Ferrer; Maike Sander; Mathias Heikenwalder; Roland M Schmid; Jens T Siveke; Fabian Geisler
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

Review 10.  Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances.

Authors:  Keisaku Sato; Marco Marzioni; Fanyin Meng; Heather Francis; Shannon Glaser; Gianfranco Alpini
Journal:  Hepatology       Date:  2018-12-27       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.